Akèy › Dyabèt Tip 2 › Nebraska
Etid klinik pou Dyabèt Tip 2 nan Nebraska
14 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan Nebraska.
Vil nan Nebraska
Tèks ofisyèl etid la (Anglè)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Methodist Physicians Clinic, Fremont
- Quality Clinical Research - Omaha, Omaha
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Bryan Heart, Lincoln
Ap rekriteVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06112418A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- University Of Nebraska Medical Center, Omaha
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Omaha
- Research Site, Omaha
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- University of Nebraska Medical Center, Omaha
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Omaha
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Velocity Clinical Research, Lincoln, Lincoln
- Velocity Clinical Research, Omaha, Omaha
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Omaha
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Methodist Phys. Clinic, Omaha
Ap rekriteFaz 3
Laj 45 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Elkhorn
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662109Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- Methodist Physicians Clinic, Fremont
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT07527650HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
- Velocity Clinical Research Norfolk, Norfolk
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07546929Blood Markers of Early Pancreas Cancer
- Unversity of Nebraska Medical Center, Omaha
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 ak plis · Tout sèks · Mizajou Feb 2, 2026 · NCT03568630SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
- University of Nebraska Medical Center, Omaha
Ap rekrite
Laj 19 a 89 · Tout sèks · Mizajou Oct 22, 2025 · NCT06480786Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.